Studies on the Anti-Inflammatory Activity of Phytopharmaceuticals Prepared from Arnica Flowers[1]

Abstract

Phytopharmaceuticals prepared from flowerheads of Arnica montana of Spanish origin and of the new type ”Arbo”, which can be easily and economically cultivated, were studied for their capability to impair activation of the transcription factors NF-κB and NF-AT. Both proteins are responsible for the transcription of genes encoding various inflammatory mediators. Additionally, their influence on the release of the cytokines IL-1 and TNF-α were examined. The inhibitory activities correlate with their quantitative and qualitative content of sesquiterpene lactones (Sls). Moreover, it was shown that the inhibitory potency of 11α,13-dihydrohelenalin derivatives being the main Sls in the Spanish flowers depend on their esterfication. Compounds with unsaturated acyl moieties, such as methacrylate and tiglinate, exhibited a stronger activity in the NF-κB EMSA as well as in the croton oil ear test in mice than the acetate derivative.

Abbreviations

Arbo tincture:tincture prepared from Arnica flowerheads
type Arbo

AP-1:activator protein 1

BSA:bovine serum albumen

c.p.m.:counts per minute

DTT:dithiothreitol

EDTA:ethylenediaminetetraacetic acid

EGTA:ethylene glycol-bis(β-aminoethyl ether)-
N,N,N′,N′-tetraacetic acid

EMSA:electrophoretic mobility shift assay

FCS:fetal calf serum

HEPES:N-[2-hydroxyethyl]-piperazine-N′-
[2-ethanesulfonic acid]

IL:interleukin

NP-40:nonylphenoxypolyethoxyethanol

NF-AT:nuclear factor of activated T cells

BPS:phosphate buffered saline

PMA:phorbol myristate acetate

PMSF:phenylmethylsulfonyl fluoride

Poly (dI-dC):polydeoxyinosinicdeoxycytidylic acid,
double-stranded alternating copolymer

Spanish tincture:tincture prepared from Spanish Arnica
flowerheads

Sl:sesquiterpene lactone

TNF-α:tumor necrosis factor alpha

Arnica montana - Asteraceae - anti-inflammatory activity - sesquiterpene lactones - NF-κB - NF-AT - IL-1β - TNF-α - mouse ear edema

References

• 1 Willuhn G. Arnica Flowers; Pharmacology, toxicology and analysis of the sesquiterpene lactones - their main active substances.  In: Phytomedicines of Europe. Chemistry and biological activity. Lawson LD, Bauer R, Eds. ACS Symposium Series 691 Washington, DC; American Chemical Society 1998: 118-32
• 2 Lyß G, Schmidt T J, Merfort I, Pahl H L. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-κB.  Biological Chemistry. 1997;  378 951-61
• 3 Lyß G, Knorre A, Schmidt T J, Pahl H L, Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65.  Journal of Biological Chemistry. 1998;  273 33 508-16
• 4 Lyß G, Schmidt T J, Pahl H L, Merfort I. Anti-inflammatory activity of Arnica tincture (DAB 1998) using the transcription factor NF-κB as molecular target.  Pharmaceutical and Pharmacological Letters. 1999;  9 5-8
• 5 Lyß G. Thesis. University Freiburg 2000
• 6 Tak P P, Firestein G S. NF-κB: a key role in inflammatory diseases.  The Journal of Clinical Investigation. 2001;  107 7-11
• 7 Serfling E, Berberich-Siebelt F, Chuvpilo S, Jankevics E, Klein-Hessling S, Twardzik T, Avots A. The role of NF-AT transcription factors in T cell activation and differentiation.  Biochimica et Biophysica Acta. 2000;  1498 1-18
• 8 von Raison J, Heilmann J, Merfort I, Schmidt T J, Brock F E, Leven W, Bomme U, Bauer R. Arnika - Arzneipflanze mit Tradition und Zukunft.  Zeitschrift für Phytotherapie. 2000;  21 39-54
• 9 Willuhn G, Röttger P M, Wendisch D. Helenalin- und 11α,13-Dihydrohelenalinester aus Blüten von Arnica montana .  Planta Medica. 1984;  50 35-7
• 10 Willuhn G, Leven W. Zur qualitativen und quantitativen Analyse der Sesquiterpenlactone von Arnikablüten DAB 9.  Pharmazeutische Zeitung - Wissenschaft. 1991;  136 32-9
• 11 Schreiber E, Matthias P, Müller M M, Schaffner W. Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells.  Nucleic Acids Research. 1989;  11 6419
• 12 Cockerill P N, Shannon M F, Bert A G, Ryan G R, Vadas M A. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer.  Procccedings of the National Academy of Science. 1993;  90 2455-70
• 13 Ausubel F M, Brent R, Kingston R E, Moore D D, Seidmann J, Smith J A, Struhl e ditors. In: Current Protocols in Molecular Biology. J. Wiley and Sons New York; 1998: 11.5.1
• 14 Tubaro A, Dri P, Delbello G, Zilli C, Della Loggia R. The croton oil ear test revisited.  Agents and Actions. 1985;  17 347-9
• 15 Lee J C, Laydon J T, McDonnell P C, Gallagher T F, Kumar S, Green D, McNulty D, Blumenthal M J, Heys J R, Landvatter S W, Strickler J E, McLaughlin M M, Siemens I R, Fisher S M, Livi G P, White J R, Adams J L, Young P R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.  Nature. 1994;  372 739-46
• 16 Rüngeler P, Castro V, Mora G, Gören N, Vichnewski W, Pahl H L, Merfort I, Schmidt T J. Inhibition of transcription factor NF-κB by sesquiterpene lactones - a proposed molecular mechanism of action and structure activity relationships.  Bioorganic & Medinal Chemistry. 1999;  7 2343-52
• 17 Scott D L, Willoughby D A, Blake D R. Molecular insights into rheumatoid arthritis.  Molecular Aspects of Medicine. 1991;  12 341-94
• 18 Koch E; Klaas C A, Rüngeler P, Castro V, Mora G, Vichnewski W, Merfort I. Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-κB.  Biochemical Pharmacology. 2001;  62 795-801
• 19 Towbin H, Pignat W, Wiesenberg I. Time-dependent cytokine production in the croton oil-induced mouse ear oedema and inhibition by prednisolone.  Inflammation Research. 1995 (Supplement);  44 S160-1
• 20 Schreiber S L, Crabtree G R. The mechanism of action of cyclosporin A and FK506.  Immunology Today. 1992;  13 136-42
• 21 Chen R, Burke T F, Cumberland J E, Brummet M, Beck L A, Casolaro V, Georas S N. Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter.  Journal of Immunology. 2000;  164 825-32
• 22 De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, Haegeman G. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell.  Proceedings of the National Academy of Sciences. 2000;  97 3919-24

1 Partly presented at the 3^rd International Congress on Phytomedicine, 2000, Munich, Germany.